(Q43488224)

23 November 2017

title

Oral treatment for gastric cancer: new choices, better choices? (English)

1 reference

23 November 2017

Stefanu Cascinu

1

1 reference

23 November 2017

publication date

1 March 2008

1 reference

Lancet Oncology Commission

23 November 2017

published in

1 reference

23 November 2017

volume

9

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

188-189

1 reference

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970042-1

7 January 2021

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970042-1

7 January 2021

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970042-1

7 January 2021

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970042-1

7 January 2021

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970042-1

7 January 2021

Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970042-1

7 January 2021

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970042-1

7 January 2021

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970042-1

7 January 2021

10.1016/S1470-2045(08)70042-1

Identifiers

DOI

1 reference

23 November 2017

1 reference